Vanda Pharmaceuticals (VNDA) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to -$22.6 million.
- Vanda Pharmaceuticals' Profit After Tax fell 32422.99% to -$22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.2 million, marking a year-over-year decrease of 41378.45%. This contributed to the annual value of -$18.9 million for FY2024, which is 85328.82% down from last year.
- As of Q3 2025, Vanda Pharmaceuticals' Profit After Tax stood at -$22.6 million, which was down 32422.99% from -$27.2 million recorded in Q2 2025.
- Vanda Pharmaceuticals' Profit After Tax's 5-year high stood at $9.7 million during Q2 2021, with a 5-year trough of -$29.5 million in Q1 2025.
- Its 5-year average for Profit After Tax is -$3.0 million, with a median of $137000.0 in 2023.
- In the last 5 years, Vanda Pharmaceuticals' Profit After Tax skyrocketed by 167983.54% in 2021 and then crashed by 398613.14% in 2024.
- Over the past 5 years, Vanda Pharmaceuticals' Profit After Tax (Quarter) stood at $7.1 million in 2021, then dropped by 3.07% to $6.9 million in 2022, then crashed by 134.98% to -$2.4 million in 2023, then crashed by 104.67% to -$4.9 million in 2024, then plummeted by 359.81% to -$22.6 million in 2025.
- Its last three reported values are -$22.6 million in Q3 2025, -$27.2 million for Q2 2025, and -$29.5 million during Q1 2025.